An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Mayo Clinic Comprehensive Cancer Center experts highlight breast cancer research that may reduce or eliminate the need for chemotherapy and endocrine treatments and may allow for shorter and less ...

Should I tell relatives I'm taking a weight loss drug? That’s up to you. Eating habits are on display with Thanksgiving meal.

Both rare and aggressive, triple-negative breast cancer accounts for 10-15% of all breast cancers. Dr. Bhardwaj says, “TNBC ...

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have recently developed a ...

GIM conducts independent research in innovative technologies and overall, more than 16,000 patients have been involved in approximately 30 studies conducted by the group so far. According to the ...

Diabetes drug development gets an advance in study that shows Inceptor binds excess insulin within the beta cell and directs it towards degradation.

A new study describes an exciting discovery that changes the way we understand human bitter taste receptors. The research has ...

The Lehigh Valley Topper Cancer institute has announced that it is now offering treatment using autologous chimeric antigen ...